olanzapine
| GeneID | Mean_1 | Mean_3 | StDev_1 | StDev_3 | T-Statistic | p-value | Symbol | Description | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 43 | 6.1 | 6.4 | 0.4 | 0.3 | 1.045 | 0.3591 | ACHE | acetylcholinesterase (Yt blood group) |
| 2 | 148 | 4.9 | 5.1 | 0.0 | 0.2 | 1.240 | 0.3337 | ADRA1A | adrenoceptor alpha 1A |
| 3 | 181 | 5.1 | 3.6 | 0.1 | 0.0 | -27.483 | 0.0001 | AGRP | agouti related neuropeptide |
| 4 | 196 | 9.6 | 8.4 | 0.3 | 0.2 | -6.697 | 0.0045 | AHR | aryl hydrocarbon receptor |
| 5 | 497258 | 6.3 | 5.8 | 0.2 | 0.5 | -1.503 | 0.2521 | BDNF-AS | BDNF antisense RNA |
| 6 | 637 | 13.4 | 12.8 | 0.2 | 0.2 | -3.251 | 0.0322 | BID | BH3 interacting domain death agonist |
| 7 | 79866 | 7.8 | 8.8 | 0.3 | 0.3 | 3.682 | 0.0221 | BORA | bora, aurora kinase A activator |
| 8 | 885 | 3.4 | 2.3 | 1.8 | 0.0 | -1.006 | 0.4204 | CCK | cholecystokinin |
| 9 | 81620 | 13.0 | 13.5 | 0.6 | 0.1 | 1.278 | 0.3241 | CDT1 | chromatin licensing and DNA replication factor 1 |
| 10 | 1080 | 2.4 | 2.4 | 0.0 | 0.0 | 1.191 | 0.2996 | CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
| 11 | 1128 | 11.4 | 10.7 | 0.1 | 0.3 | -3.508 | 0.0569 | CHRM1 | cholinergic receptor, muscarinic 1 |
| 12 | 1132 | 4.7 | 5.4 | 0.2 | 0.3 | 3.175 | 0.0382 | CHRM4 | cholinergic receptor, muscarinic 4 |
| 13 | 1133 | 2.8 | 3.1 | 0.4 | 0.3 | 0.975 | 0.3954 | CHRM5 | cholinergic receptor, muscarinic 5 |
| 14 | 1268 | 2.2 | 2.4 | 0.0 | 0.1 | 1.848 | 0.2050 | CNR1 | cannabinoid receptor 1 (brain) |
| 15 | 114757 | 13.4 | 13.0 | 0.1 | 0.2 | -2.755 | 0.0760 | CYGB | cytoglobin |
| 16 | 1558 | 2.2 | 2.8 | 0.0 | 0.6 | 1.477 | 0.2775 | CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 |
| 17 | 4921 | 2.6 | 2.9 | 0.4 | 0.4 | 0.964 | 0.3899 | DDR2 | discoidin domain receptor tyrosine kinase 2 |
| 18 | 1659 | 10.9 | 10.3 | 0.1 | 0.0 | -8.652 | 0.0053 | DHX8 | DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
| 19 | 1812 | 2.9 | 2.7 | 0.3 | 0.2 | -1.006 | 0.3803 | DRD1 | dopamine receptor D1 |
| 20 | 1813 | 2.3 | 3.5 | 0.2 | 1.2 | 1.798 | 0.2086 | DRD2 | dopamine receptor D2 |
| 21 | 1814 | 2.8 | 3.0 | 0.5 | 0.7 | 0.549 | 0.6148 | DRD3 | dopamine receptor D3 |
| 22 | 2243 | 2.5 | 2.5 | 0.2 | 0.1 | -0.438 | 0.6927 | FGA | fibrinogen alpha chain |
| 23 | 2548 | 15.0 | 14.7 | 0.1 | 0.2 | -2.315 | 0.1147 | GAA | glucosidase, alpha; acid |
| 24 | 2641 | 3.4 | 3.2 | 0.3 | 0.1 | -0.748 | 0.5163 | GCG | glucagon |
| 25 | 2671 | 8.3 | 8.1 | 0.4 | 0.1 | -0.646 | 0.5733 | GFER | growth factor, augmenter of liver regeneration |
| 26 | 2996 | 2.3 | 2.3 | 0.0 | 0.0 | -0.435 | 0.6861 | GYPE | glycophorin E (MNS blood group) |
| 27 | 3043 | 2.4 | 2.4 | 0.0 | 0.0 | 0.209 | 0.8450 | HBB | hemoglobin, beta |
| 28 | 3290 | 2.7 | 2.3 | 0.7 | 0.0 | -0.995 | 0.4239 | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
| 29 | 3350 | 2.6 | 2.2 | 0.6 | 0.0 | -0.999 | 0.4228 | HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
| 30 | 3351 | 3.9 | 4.0 | 0.6 | 0.4 | 0.131 | 0.9025 | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
| 31 | 3352 | 2.8 | 3.1 | 0.5 | 0.4 | 0.813 | 0.4657 | HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
| 32 | 3354 | 2.4 | 2.4 | 0.1 | 0.2 | -0.036 | 0.9731 | HTR1E | 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
| 33 | 3355 | 2.2 | 4.7 | 0.0 | 0.5 | 8.316 | 0.0141 | HTR1F | 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
| 34 | 3356 | 2.1 | 2.1 | 0.0 | 0.0 | -0.899 | 0.4278 | HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
| 35 | 3358 | 6.0 | 3.1 | 0.1 | 0.6 | -8.207 | 0.0112 | HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
| 36 | 3359 | 2.7 | 3.2 | 0.2 | 0.2 | 2.328 | 0.0805 | HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
| 37 | 3360 | 2.4 | 2.3 | 0.2 | 0.1 | -0.720 | 0.5356 | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
| 38 | 3362 | 2.8 | 3.5 | 0.5 | 0.5 | 1.894 | 0.1319 | HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
| 39 | 3363 | 10.2 | 8.8 | 0.4 | 0.1 | -6.564 | 0.0125 | HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
| 40 | 3064 | 9.8 | 10.0 | 0.1 | 0.1 | 3.101 | 0.0366 | HTT | huntingtin |
| 41 | 3569 | 2.3 | 2.3 | 0.0 | 0.0 | -0.440 | 0.6964 | IL6 | interleukin 6 |
| 42 | 3630 | 3.6 | 4.1 | 0.4 | 0.4 | 1.716 | 0.1617 | INS | insulin |
| 43 | 3952 | 2.6 | 2.6 | 0.2 | 0.2 | 0.503 | 0.6416 | LEP | leptin |
| 44 | 23530 | 5.7 | 5.7 | 0.1 | 0.3 | 0.102 | 0.9267 | NNT | nicotinamide nucleotide transhydrogenase |
| 45 | 55558 | 11.7 | 11.8 | 0.2 | 0.2 | 0.458 | 0.6717 | PLXNA3 | plexin A3 |
| 46 | 80339 | 7.4 | 7.5 | 0.1 | 0.2 | 0.580 | 0.6004 | PNPLA3 | patatin-like phospholipase domain containing 3 |
| 47 | 5443 | 3.0 | 3.3 | 0.4 | 0.6 | 0.757 | 0.5017 | POMC | proopiomelanocortin |
| 48 | 5617 | 2.3 | 2.2 | 0.0 | 0.0 | -0.781 | 0.4880 | PRL | prolactin |
| 49 | 5999 | 9.6 | 9.5 | 0.0 | 0.0 | -2.425 | 0.1301 | RGS4 | regulator of G-protein signaling 4 |
| 50 | 5345 | 3.1 | 2.5 | 0.6 | 0.3 | -1.429 | 0.2594 | SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
| 51 | 6865 | 6.3 | 6.3 | 0.2 | 0.0 | 0.372 | 0.7439 | TACR2 | tachykinin receptor 2 |
| 52 | 7124 | 3.9 | 4.1 | 2.4 | 0.7 | 0.111 | 0.9206 | TNF | tumor necrosis factor |
| 53 | 115650 | 5.7 | 5.4 | 0.7 | 0.3 | -0.649 | 0.5676 | TNFRSF13C | tumor necrosis factor receptor superfamily, member 13C |